Yamaguchi, Kensei http://orcid.org/0000-0001-6887-5709
Boku, Narikazu
Muro, Kei
Yoshida, Kazuhiro
Baba, Hideo
Tanaka, Shinji
Akamatsu, Ayumi
Sano, Takeshi
Funding for this research was provided by:
Ono Pharmaceutical
Bristol-Myers Squibb
Article History
Received: 20 April 2021
Accepted: 26 August 2021
First Online: 28 September 2021
Change Date: 9 November 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10120-021-01262-w
Declarations
:
: KYa has received research funding from Ono Pharmaceutical Co., Ltd., and Bristol-Myers Squibb for the work under consideration for publication. KYa has also received grants from Taiho Pharmaceutical, Yakult Honsha, Sanofi, Ono Pharmaceutical Co., Ltd., and Elli Lilly; and honoraria from Taiho Pharmaceutical, Chugai Pharmaceutical, Ono Pharmaceutical Co., Ltd., Eli Lilly, Bristol-Myers Squibb Japan, Merck Serono, and Takeda Pharmaceutical outside the submitted work. NB has received research funding from Ono Pharmaceutical Co., Ltd., and Bristol-Myers Squibb for the work under consideration for publication. NB has also received grants from Takeda Pharmaceutical and Ono Pharmaceutical Co., Ltd.; and honoraria for lectures from Ono Pharmaceutical Co., Ltd., Taiho Pharmaceutical, and Bristol-Myers Squibb outside the submitted work. KM has received grants from Ono Pharmaceutical Co., Ltd. and Bristol-Myers Squibb for the work under consideration for publication. KM has also received grants and personal fees from Amgen (research funding and consulting fee), Ono Pharmaceutical Co., Ltd. (research funding, consulting fee, and honorarium), Sanofi (research funding and honorarium), and Taiho Pharmaceutical (research funding and honorarium); grants (research funding) from Solasia Pharma, Merck Serono, Daiichi Sankyo, Parexel International, Pfizer, and MSD; and personal fees from AstraZeneca (consulting fee), Chugai Pharmaceutical (honorarium), Takeda Pharmaceutical, Eli Lilly, Bristol-Myers Squibb, and Bayer outside the submitted work. KYo has received grants and personal fees from Ono Pharmaceutical Co., Ltd. and Bristol-Myers Squibb for the work under consideration for publication. KY has also received grants and personal fees from Asahi Kasei Pharma, Chugai Pharmaceutical, Covidien Japan, Daiichi Sankyo, Eli Lilly Japan, Johnson and Johnson, Merck Serono, MSD, Nippon Kayaku, Novartis Pharma, Sanofi, Taiho Pharmaceutical, Takeda Pharmaceutical, Tsumura and Co., and Yakult Honsha; grants from Abbott, AbbVie, Astellas, Biogen Japan, Celgene, Eisai, EPâCRSU, Fujifilm, GlaxoSmithKline K.K., Kaken Pharmaceutical, Kyowa Kirin, Meiji Seika Pharma, Otsuka Pharmaceutical, Koninklijke Philips, and Toray Medical; and personal fees from AstraZeneca, Denka Co., Ltd., EA Pharma, Olympus, Pfizer, Sanwa Kagaku Kenkyusho, SBI Pharma, Teijin Pharma, and Terumo outside the submitted work. HB has received grants from Ono Pharmaceutical Co., Ltd. and Bristol-Myers Squibb for the work under consideration for publication. HB has also received grants and personal fees from Ono Pharmaceutical Co., Ltd. and Taiho Pharmaceutical; grants from Merck Biopharma Co., Ltd. and MSD K.K.; and personal fees from Eli Lilly Japan K.K. outside the submitted work. AA and ST are employees of and own stocks in Ono Pharmaceutical Co., Ltd. TS has received research funding from Ono Pharmaceutical Co. Ltd., and Bristol-Myers Squibb for the work under consideration for publication. TS has also received lecture fees from Ono Pharmaceutical Co. Ltd., Taiho Pharmaceutical, Eli Lilly, Chugai Pharmaceutical, EA Pharma, Daiichi Sankyo, Takeda Pharmaceutical, and Nippon Kayaku outside the submitted work.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. This was a noninterventional study conducted in routine clinical practice; therefore, in accordance with good postmarketing study practice regulations, written informed consent of patients was not required.